1. Home
  2. UPLD vs CTNM Comparison

UPLD vs CTNM Comparison

Compare UPLD & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPLD
  • CTNM
  • Stock Information
  • Founded
  • UPLD 2010
  • CTNM 2009
  • Country
  • UPLD United States
  • CTNM United States
  • Employees
  • UPLD N/A
  • CTNM N/A
  • Industry
  • UPLD Computer Software: Prepackaged Software
  • CTNM
  • Sector
  • UPLD Technology
  • CTNM
  • Exchange
  • UPLD Nasdaq
  • CTNM Nasdaq
  • Market Cap
  • UPLD 115.3M
  • CTNM 114.1M
  • IPO Year
  • UPLD 2014
  • CTNM 2024
  • Fundamental
  • Price
  • UPLD $1.81
  • CTNM $4.75
  • Analyst Decision
  • UPLD Hold
  • CTNM Strong Buy
  • Analyst Count
  • UPLD 1
  • CTNM 4
  • Target Price
  • UPLD N/A
  • CTNM $22.50
  • AVG Volume (30 Days)
  • UPLD 137.9K
  • CTNM 122.7K
  • Earning Date
  • UPLD 07-31-2025
  • CTNM 05-14-2025
  • Dividend Yield
  • UPLD N/A
  • CTNM N/A
  • EPS Growth
  • UPLD N/A
  • CTNM N/A
  • EPS
  • UPLD N/A
  • CTNM N/A
  • Revenue
  • UPLD $267,713,000.00
  • CTNM N/A
  • Revenue This Year
  • UPLD N/A
  • CTNM N/A
  • Revenue Next Year
  • UPLD N/A
  • CTNM N/A
  • P/E Ratio
  • UPLD N/A
  • CTNM N/A
  • Revenue Growth
  • UPLD N/A
  • CTNM N/A
  • 52 Week Low
  • UPLD $1.75
  • CTNM $3.35
  • 52 Week High
  • UPLD $5.64
  • CTNM $22.00
  • Technical
  • Relative Strength Index (RSI)
  • UPLD 27.36
  • CTNM N/A
  • Support Level
  • UPLD $2.12
  • CTNM N/A
  • Resistance Level
  • UPLD $1.97
  • CTNM N/A
  • Average True Range (ATR)
  • UPLD 0.18
  • CTNM 0.00
  • MACD
  • UPLD -0.05
  • CTNM 0.00
  • Stochastic Oscillator
  • UPLD 5.45
  • CTNM 0.00

About UPLD Upland Software Inc.

Upland Software Inc is a provider of cloud-based enterprise work management software. The company provides a family of cloud-based enterprise work management software applications for the information technology, process excellence, finance, professional services and marketing functions within organizations. It services customers ranging from corporations and Government agencies to small- and medium-sized businesses engaged in the field of financial services, retail, technology, manufacturing, education, consumer goods, media, and telecommunications, Government, food and beverage, healthcare and life sciences, chemicals and travel and hospitality. The products of the company are Altify, BA Insight, InGenius, Panviva, Qvidian, RightAnswers and others.

About CTNM Contineum Therapeutics Inc. Class A Common Stock

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

Share on Social Networks: